Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Middle Meningeal Artery (MMA) Embolization for Patients With Chronic Subdural Hematoma (cSDH)

NCT04065113 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04065113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04065113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Middle Meningeal Artery (MMA) Embolization for Patients With Chronic Subdural Hematoma (cSDH)
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Withdrawn
Start date
September 19, 2019
Completion date
June 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma